Loading
ML
Mesoblast Ltd Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by George Gregory, was filed 13 Apr 2026.
Insider Decl.
21
Thresholds
n/a
Buy Volume
€17M
21 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleGregory George21 buys
Since the insiders bought
- -3.1%Entry US$1.60 · Close at T+90 US$1.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,443 of 26,246 companies
32.3
score / 100
Value26
Quality38
FCF yld-2.4%
Earn yld-3.1%
EV/EBITDA·
ROE-9.9%
Gross mgn86%
Net mgn-48%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
US$14.27
Analyst consensus
2 analystsUS$35.00Target US$37.00(+159%)US$39.00
Income statement
RevenueUS$120.3M
Gross profitUS$103.6M86% margin
EBITDA-US$37M-31% margin
Net income-US$57.5M-47.8% margin
Valuation
PER (forward)31.4x
P/Book3.3x
Beta0.86
Balance sheet & cash
Market capUS$1.9B
Total debtUS$127.3M
Free Cash Flow-US$44.7M
Debt / Equity22%
Profitability & ownership
ROE-9.9%
ROA-4.1%
% insiders57.4%
% institutions3.3%
Last declaration on 13 April 2026
Declarations21 total
105,000 shares@ US$1.460.8% of flowOrdinary SharesSEC:0001999371-26-008132:2
Canonical exit: 8 Jul 2026 (T+90)
500,000 shares@ US$1.443.7% of flowOrdinary SharesSEC:0001999371-26-008132:3
Canonical exit: 8 Jul 2026 (T+90)
10,000 shares@ US$1.440.1% of flowOrdinary SharesSEC:0001999371-26-008132:4
Canonical exit: 8 Jul 2026 (T+90)
20,000 shares@ US$1.430.1% of flowOrdinary SharesSEC:0001999371-26-008132:6
Canonical exit: 8 Jul 2026 (T+90)
5,240 shares@ US$1.430.0% of flowOrdinary SharesSEC:0001999371-26-008132:8
Canonical exit: 8 Jul 2026 (T+90)
5,000 shares@ US$1.430.0% of flowOrdinary SharesSEC:0001999371-26-008132:10
Canonical exit: 8 Jul 2026 (T+90)
10,000 shares@ US$1.410.1% of flowOrdinary SharesSEC:0001999371-26-008132:13
Canonical exit: 8 Jul 2026 (T+90)
4,760 shares@ US$1.440.0% of flowOrdinary SharesSEC:0001999371-26-008132:5
Canonical exit: 8 Jul 2026 (T+90)
10,000 shares@ US$1.430.1% of flowOrdinary SharesSEC:0001999371-26-008132:7
Canonical exit: 8 Jul 2026 (T+90)
500,000 shares@ US$14.3936.5% of flowOrdinary SharesSEC:0001999371-26-008124:2
Canonical exit: 8 Jul 2026 (T+90)
10,000 shares@ US$14.400.7% of flowOrdinary SharesSEC:0001999371-26-008124:4
Canonical exit: 8 Jul 2026 (T+90)
4,760 shares@ US$14.400.3% of flowOrdinary SharesSEC:0001999371-26-008124:5
Canonical exit: 8 Jul 2026 (T+90)
20,000 shares@ US$14.301.5% of flowOrdinary SharesSEC:0001999371-26-008124:6
Canonical exit: 8 Jul 2026 (T+90)
10,000 shares@ US$14.300.7% of flowOrdinary SharesSEC:0001999371-26-008124:7
Canonical exit: 8 Jul 2026 (T+90)
5,240 shares@ US$14.250.4% of flowOrdinary SharesSEC:0001999371-26-008124:8
Canonical exit: 8 Jul 2026 (T+90)
10,000 shares@ US$14.250.7% of flowOrdinary SharesSEC:0001999371-26-008124:9
Canonical exit: 8 Jul 2026 (T+90)
5,000 shares@ US$14.300.4% of flowOrdinary SharesSEC:0001999371-26-008124:10
Canonical exit: 8 Jul 2026 (T+90)
10,000 shares@ US$14.100.7% of flowOrdinary SharesSEC:0001999371-26-008124:13
Canonical exit: 8 Jul 2026 (T+90)
2,324,072 shares@ US$1.4817.5% of flowOrdinary SharesSEC:0001999371-26-008124:14
Canonical exit: 9 Jul 2026 (T+90)
886,890 shares@ US$1.436.4% of flowOrdinary SharesSEC:0001999371-26-008124:1
Canonical exit: 8 Jul 2026 (T+90)
4,000,000 shares@ US$1.4229.2% of flowOrdinary SharesSEC:0001999371-26-008124:0
Canonical exit: 3 Jul 2026 (T+90)
21 of 21 declarations
About Mesoblast Ltd
Every one of the 21 filings for Mesoblast Ltd comes from a single filer, Gregory George, listed as a director, and every one is an open-market purchase. The trades run from April 4 to April 10, 2026, and the filings were published between April 10 and April 13, 2026, a median of one day after the trade.
The purchases add up to EUR 16.8 million (EUR 16,844,954), with a median of EUR 120,603. Three of them stand out: EUR 6,154,172 on April 9, 2026, EUR 4,921,265 on April 4, 2026 and EUR 2,942,050 on April 10, 2026. There is no sale, grant or option exercise on record.
Read moreShow less
Mesoblast is classed in Health Care and carries a market capitalisation of USD 1.85 billion. Insiders hold 57.4% of the shares according to market data. For the 21 purchases a 90-day result is stored: a median of -3.1% and no positive outcome. These are stored past results, not a forecast. All 21 filings fall within the last twelve months.
